Default: Current Medicinal Chemistry

ISSN: 0929-8673

Journal Home

Journal Guideline

Current Medicinal Chemistry Q1 Unclaimed

Bentham Science Publishers B.V. United Arab Emirates
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Current Medicinal Chemistry is a journal indexed in SJR in Biochemistry and Drug Discovery with an H index of 167. It has an SJR impact factor of 0,903 and it has a best quartile of Q1. It is published in English.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -


Current Medicinal Chemistry


SJR Impact factor


H Index


Total Docs (Last Year)


Total Docs (3 years)


Total Refs


Total Cites (3 years)


Citable Docs (3 years)


Cites/Doc (2 years)



Best articles

99mTc-labeled Small Molecules for Diagnosis of Alzheimer's Disease: Past, Recent and Future Perspectives

View more

Advances in Carbon Based Nanomaterials for Bio-Medical Applications

View more

Amino Acid Degrading Enzymes and their Application in Cancer Therapy

View more

An Over Four Millennium Story Behind Qinghaosu (Artemisinin)-A Fantastic Antimalarial Drug from a Traditional Chinese Herb

View more

Antifungal Drug Discovery through the Study of Invertebrate Model Hosts

View more

Bioactive Sesquiterpenes Produced by Fungi are they Useful for Humans as Well

View more

Biomedical Applications of Synthetic, Biodegradable Polymers for the Development of Anti-Infective Strategies

View more

Biotechnological Production of Pharmaceuticals and Biopharmaceuticals in Plant Cell and Organ Cultures

View more

Boronate Can Be the Fluorogenic Switch for the Detection of Hydrogen Peroxide

View more

Cannabinoids: Occurrence and Medicinal Chemistry

View more

Cardiovascular Effects of Flavonoids

View more

Cdc42 Signaling Pathway Inhibition as a Therapeutic Target in Ras- Related Cancers

View more

Chagas Disease: Progress and New Perspectives

View more

Chemistry and Biochemistry of 2, 5-Oligoadenylate-Based Antisense Strategy

View more

Clinical Trial Update and Novel Therapeutic Approaches for Metastatic Prostate Cancer

View more

Combretastatin A-4 Analogues as Antimitotic Antitumor Agents

View more

Computational Modelling of Magnetic Nanoparticle Properties and In Vivo Responses

View more

Connexins as Precocious Markers and Molecular Targets for Chemical and Pharmacological Agents in Carcinogenesis

View more

Copper Transport Systems are Involved in Multidrug Resistance and Drug Transport

View more

COX-2 Expression in Atherosclerosis: The Good, the Bad or the Ugly?

View more

Current Limitations in the Treatment of Parkinson's and Alzheimer's Diseases: State-of-the-Art and Future Perspective of Polymeric Carriers

View more

Delivering Drugs to the Central Nervous System: A Medicinal Chemistry or a Pharmaceutical Technology Issue?

View more

Dendrimer-Modified Solid Supports: Nanostructured Materials with Potential Drug Allergy Diagnostic Applications

View more

Development of Low Molecular Weight CXCR4 Antagonists by Exploratory Structural Tuning of Cyclic Tetra- and Pentapeptide-Scaffolds Towards the Treatment of HIV Infection, Cancer Metastasis and Rheumatoid Arthritis

View more


No comments ... Be the first to comment!